These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 767355)

  • 1. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
    Maciel RM; Miki SS; Nicolau W; Mendes NF
    J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism.
    Mulaisho C; Abdou NI; Utiger RD
    J Clin Endocrinol Metab; 1975 Aug; 41(2):266-70. PubMed ID: 1080488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of peripheral B lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Kabutomori O; Asari S; Motoi S; Miyai K; Kumahara Y
    Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible nonspecific immunopotentiation by 2,4-dinitrochlorobenzene sensitization in patients with Hodgkin's disease.
    Rubinstein A; Ghossein NA; Melamed J; Bosworth JL; Murphy RA
    Oncology; 1979; 36(1):23-6. PubMed ID: 313034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
    Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
    J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S; Haftek M; Sliński W
    Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease.
    Hsu CC; Chen Y; Patterson R
    Clin Exp Immunol; 1976 Dec; 26(3):431-40. PubMed ID: 64326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal T cell population in chronic lymphocytic leukemia: analysis of phytohemagglutinin dose-response curves.
    Ziegler JB; Hansen PJ; Davies WA; Penny R
    J Reticuloendothel Soc; 1974 Nov; 16(5):269-75. PubMed ID: 4216631
    [No Abstract]   [Full Text] [Related]  

  • 14. B- and T-lymphocytes in toxic diffuse goitre.
    Sköldstam L; Anderberg B; Norrby K
    Clin Exp Immunol; 1978 Mar; 31(3):524-5. PubMed ID: 350461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative study of T and B lymphocytes in Hodgkin's disease.
    Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
    Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T- and B-lymphocytes in lymphogranulomatosis].
    Il'in NV; Letskiĭ VB; Vinokurova NA
    Vopr Onkol; 1977; 23(6):9-15. PubMed ID: 303412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
    Wall JR; Chartier B
    J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T- and B-lymphocytes in peripheral blood of children and adolescents with Graves' disease].
    Rybakowa M; Mytar B; Sołtysik-Wilk E; Pleti M; Mizerski J
    Endokrynol Pol; 1979; 30(4):361-6. PubMed ID: 315308
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
    Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
    J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.